Mantle cell lymphoma patients in first relapse: we pretty much know what to do

Oncotarget. 2021 Aug 17;12(17):1724-1726. doi: 10.18632/oncotarget.27980.
No abstract available

Keywords: POD; ibrutinib; mantle cell lymphoma; relapsed-refractory MCL; treatment algorithm.

Publication types

  • Editorial